Zöliakie und Weizensensitivität im Wandel – ein Update

Sina Hübener; Carolin Friederike Manthey

doi:10.1055/a-0862-8207

Gastroenterologie up2date, Table of Contents

Gastroenterologie up2date 2019; 15(04): 375-393
DOI: 10.1055/a-0862-8207

Darm/Anorektum

Georg Thieme Verlag KG Stuttgart · New York

Zöliakie und Weizensensitivität im Wandel – ein Update

Sina Hübener

,

Carolin Friederike Manthey

Abstract

All articles of this category

Die Zöliakie ist eine Erkrankung im Wandel – das betrifft sowohl die Präsentation der Erkrankung als auch ihre Therapie. Dieser Beitrag gibt daher ein Update zur Diagnose und zum Stand der Entwicklung neuer Therapien.

Schlüsselwörter

Zöliakie - Weizensensitivität - Gluten - glutenfreie Diät

Full Text

References

Literatur
1 Catassi C, Bai JC, Bonaz B. et al. Non-celiac gluten sensitivity: the new frontier of gluten related disorders. Nutrients 2013; 5: 3839-3853 doi:10.3390/nu5103839
2 Frieling T, Heise J, Krummen B. et al. Tolerability of FODMAP-reduced diet in irritable bowel syndrome – efficacy, adherence, and body weight course. Z Gastroenterol 2019; 57: 740-744 doi:10.1055/a-0859-7531
3 Dicke WK. Investigation of the harmful effects of certain types of cereal on patients with coeliac disease [Dissertation]. Utrecht, Netherlands: University of Utrecht; 1950: 114
4 Shiner M. Duodenal biopsy. Lancet 1956; 267: 17-19 doi:10.1016/S0140-6736(56)91854-2
5 Berger E, Buergin-Wolff A, Freudenberg E. [Diagnostic value of the demonstration of gliadin antibodies in celiac disease]. Klin Wochenschr 1964; 42: 788-790 doi:10.1007/bf01479129
6 Chorzelski TP, Sulej J, Tchorzewska H. et al. IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann N Y Acad Sci 1983; 420: 325-334 doi:10.1111/j.1749-6632.1983.tb22220.x
7 Dieterich W, Ehnis T, Bauer M. et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801
8 Shan L, Molberg O, Parrot I. et al. Structural basis for gluten intolerance in celiac sprue. Science 2002; 297: 2275-2279 doi:10.1126/science.1074129
9 Kim HS, Patel KG, Orosz E. et al. Time trends in the prevalence of celiac disease and gluten-free diet in the US population: Results from the National Health and Nutrition Examination Surveys 2009–2014. JAMA Intern Med 2016; 176: 1716-1717 doi:10.1001/jamainternmed.2016.5254
10 Grand View Research. Gluten-Free Products Market Size, Share & Trends Analysis Report By Product (Bakery Products, Dairy/Dairy Alternatives, Meat/Meat Alternatives), By Distribution (Grocery Stores, Mass Merchandiser), And Segment Forecasts, 2019–2025. März 2019. Im Internet: http://www.grandviewresearch.com/industry-analysis/gluten-free-products-market Stand: 10.10.2019
11 Statista. Umsatz mit glutenfreien Produkten im Lebensmittelhandel in Deutschland in den Jahren 2016 und 2017. Juni 2017. Im Internet: http://de.statista.com/statistik/daten/studie/257797/umfrage/umsatzwicklung-bei-glutenfreien-produkten-in-deutschland/ Stand: 10.10.2019
12 Vici G, Belli L, Biondi M. et al. Gluten free diet and nutrient deficiencies: A review. Clin Nutr 2016; 35: 1236-1241 doi:10.1016/j.clnu.2016.05.002
13 Raehsler SL, Choung RS, Marietta EV. et al. Accumulation of heavy metals in people on a gluten-free diet. Clin Gastroenterol Hepatol 2018; 16: 244-251 doi:10.1016/j.cgh.2017.01.034
14 Osborne TB. The Vegetable Proteins. 2nd. ed. London: Longmans, Green and Co.; 1924
15 Huebener S, Tanaka CK, Uhde M. et al. Specific nongluten proteins of wheat are novel target antigens in celiac disease humoral response. J Proteome Res 2015; 14: 503-511 doi:10.1021/pr500809b
16 Cichewicz AB, Mearns ES, Taylor A. et al. Diagnosis and treatment patterns in celiac disease. Dig Dis Sci 2019; 64: 2095-2106 doi:10.1007/s10620-019-05528-3
17 Kelly CP, Bai JC, Liu E. et al. Advances in diagnosis and management of celiac disease. Gastroenterology 2015; 148: 1175-1186 doi:10.1053/j.gastro.2015.01.044
18 Nachman F, Vazquez H, Gonzalez A. et al. Gastroesophageal reflux symptoms in patients with celiac disease and the effects of a gluten-free diet. Clin Gastroenterol Hepatol 2011; 9: 214-219 doi:10.1016/j.cgh.2010.06.017
19 Husby S, Koletzko S, Korponay-Szabo IR. et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54: 136-160 doi:10.1097/MPG.0b013e31821a23d0
20 Steinsbo O, Dorum S, Lundin KE. et al. Serologic assay for diagnosis of celiac disease based on a patient-derived monoclonal antigliadin antibody. Gastroenterology 2015; 149: 1530-1540.e3 doi:10.1053/j.gastro.2015.07.008
21 Oberhuber G, Caspary WF, Kirchner T. et al. Empfehlungen zur Zölliakie-/Spruediagnostik Arbeitsgemeinschaft für gastroenterologische Pathologie der Deutschen Gesellschaft für Pathologie. Pathologe 2001; 22: 72-81 doi:10.1007/s002920000428
22 Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 1992; 102: 330-354
23 Biagi F, Luinetti O, Campanella J. et al. Intraepithelial lymphocytes in the villous tip: do they indicate potential coeliac disease?. J Clin Pathol 2004; 57: 835-839 doi:10.1136/jcp.2003.013607
24 Dickson BC, Streutker CJ, Chetty R. Coeliac disease: an update for pathologists. J Clin Pathol 2006; 59: 1008-1016 doi:10.1136/jcp.2005.035345
25 Mustalahti K, Catassi C, Reunanen A. et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med 2010; 42: 587-595 doi:10.3109/07853890.2010.505931
26 Reilly NR, Green PH. Epidemiology and clinical presentations of celiac disease. Semin Immunopathol 2012; 34: 473-478 doi:10.1007/s00281-012-0311-2
27 Laass MW, Schmitz R, Uhlig HH. et al. The prevalence of celiac disease in children and adolescents in Germany. Dtsch Arztebl Int 2015; 112: 553-560 doi:10.3238/arztebl.2015.0553
28 Ludvigsson JF, Rubio-Tapia A, van Dyke CT. et al. Increasing incidence of celiac disease in a North American population. Am J Gastroenterol 2013; 108: 818-824 doi:10.1038/ajg.2013.60
29 Lionetti E, Castellaneta S, Francavilla R. et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med 2014; 371: 1295-1303 doi:10.1056/NEJMoa1400697
30 Vriezinga SL, Auricchio R, Bravi E. et al. Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med 2014; 371: 1304-1315 doi:10.1056/NEJMoa1404172
31 Pham-Short A, Donaghue KC, Ambler G. et al. Quality of life in type 1 diabetes and celiac disease: role of the gluten-free diet. J Pediatr 2016; 179: 131-138.e1 doi:10.1016/j.jpeds.2016.08.105
32 Kaur N, Bhadada SK, Minz RW. et al. Interplay between type 1 diabetes mellitus and celiac disease: implications in treatment. Dig Dis 2018; 36: 399-408 doi:10.1159/000488670
33 Meena DK, Akunuri S, Meena P. et al. Tissue transglutaminase antibody and its association with duodenal biopsy in diagnosis of pediatric celiac disease. Pediatr Gastroenterol Hepatol Nutr 2019; 22: 350-357 doi:10.5223/pghn.2019.22.4.350
34 Dahlbom I, Korponay-Szabo IR, Kovacs JB. et al. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr 2010; 50: 140-146 doi:10.1097/MPG.0b013e3181a81384
35 Jericho H, Sansotta N, Guandalini S. Extraintestinal manifestations of celiac disease: effectiveness of the gluten-free diet. J Pediatr Gastroenterol Nutr 2017; 65: 75-79 doi:10.1097/MPG.0000000000001420
36 Moreno ML, Cebolla A, Munoz-Suano A. et al. Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing. Gut 2017; 66: 250-257 doi:10.1136/gutjnl-2015-310148
37 Schiepatti A, Biagi F, Fraternale G. et al. Short article: Mortality and differential diagnoses of villous atrophy without coeliac antibodies. Eur J Gastroenterol Hepatol 2017; 29: 572-576 doi:10.1097/MEG.0000000000000836
38 Volta U, Caio G, Boschetti E. et al. Seronegative celiac disease: Shedding light on an obscure clinical entity. Dig Liver Dis 2016; 48: 1018-1022 doi:10.1016/j.dld.2016.05.024
39 Schiepatti A, Sanders DS, Zuffada M. et al. Overview in the clinical management of patients with seronegative villous atrophy. Eur J Gastroenterol Hepatol 2019; 31: 409-417 doi:10.1097/MEG.0000000000001340
40 Aziz I, Peerally MF, Barnes JH. et al. The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000–2015). Gut 2017; 66: 1563-1572 doi:10.1136/gutjnl-2016-312271
41 Schumann M, Stallmach A, Buske S. et al. Refraktäre Sprue/Zöliakie: Register soll offene Fragen klären. Dtsch Arztebl 2017; 114: A-743/B-631/C-617
42 Orphanet. Refraktäre Zöliakie, Orpha-Kennnummer: 398063. Im Internet: http://www.orpha.net/ Stand:10.10.2019
43 Rubio-Tapia A, Murray JA. Classification and management of refractory coeliac disease. Gut 2010; 59: 547-557 doi:10.1136/gut.2009.195131
44 van Gils T, Nijeboer P, van Wanrooij RL. et al. Mechanisms and management of refractory coeliac disease. Nat Rev Gastroenterol Hepatol 2015; 12: 572-579 doi:10.1038/nrgastro.2015.155
45 Malamut G, Meresse B, Cellier C. et al. Refractory celiac disease: from bench to bedside. Semin Immunopathol 2012; 34: 601-613 doi:10.1007/s00281-012-0322-z
46 Brar P, Lee S, Lewis S. et al. Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol 2007; 102: 2265-2269 doi:10.1111/j.1572-0241.2007.01380.x
47 Goerres MS, Meijer JW, Wahab PJ. et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther 2003; 18: 487-494
48 Gillett HR, Arnott ID, McIntyre M. et al. Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 2002; 122: 800-805 doi:10.1053/gast.2002.31874
49 Wahab PJ, Crusius JB, Meijer JW. et al. Cyclosporin in the treatment of adults with refractory coeliac disease – an open pilot study. Aliment Pharmacol Ther 2000; 14: 767-774
50 Mention JJ, Ben Ahmed M, Begue B. et al. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 2003; 125: 730-745 doi:10.1016/s0016-5085(03)01047-3
51 Nijeboer P, van Wanrooij RL, Tack GJ. et al. Update on the diagnosis and management of refractory coeliac disease. Gastroenterol Res Pract 2013; 2013: 518483 doi:10.1155/2013/518483
52 Krishnareddy S, Stier K, Recanati M. et al. Commercially available glutenases: a potential hazard in coeliac disease. Therap Adv Gastroenterol 2017; 10: 473-481 doi:10.1177/1756283X17690991